We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Eli Lilly v Apotex, PMNOC proceedings, strattera, October 29, 2010
  • Gowling WLG
  • Canada
  • November 24 2010

Eli Lilly sought an order of prohibition against Apotex until expiry of its patent for atomoxetine (the '735 patent


Novopharm Limited v. Eli Lilly and Company (2010 FC 915)
  • Gowling WLG
  • Canada
  • October 27 2010

An impeachment action was brought by Novopharm in respect of a patent for STRATTERA alleging obviousness, anticipation, utility and improper selection


Eli Lilly Canada Inc. v. Apotex Inc (2010 FCA 240)
  • Gowling WLG
  • Canada
  • October 27 2010

This was an appeal of the decision of Madame Justice Gauthier (in the Federal Court) who had found that although Lilly met its burden to prove that Apotex infringed eight Lilly process patents related to the manufacture of the antibiotic cefaclor for material imported before June 3, 1998, Lilly failed to do so for the cefaclor imported into Canada after June 3, 1998


Be warned: online forum selection clauses may oblige you to litigate abroad
  • Gowling WLG
  • Canada
  • June 30 2015

The decision in Douez v. Facebook, Inc., provides some comfort to online businesses that rely upon forum selection clauses in their online contracts


Impacts of the Amazon.com decisions on medical use claims in Canada
  • Gowling WLG
  • Canada
  • July 13 2012

Methods of medical treatment and surgery are not statutory subject matter in Canada


Counterfeiters face stiff penalties in Canada
  • Gowling WLG
  • Canada
  • February 10 2014

The Office of the United States Trade Representative ("USTR") publishes a report every few years called the Special 301 Report. In the report, the


Celgene Corporation v Canada (AG) - Supreme Court of Canada grants leave to appeal
  • Gowling WLG
  • Canada
  • May 21 2010

The Supreme Court of Canada has granted Celgene Corporation's application for leave to appeal the decision of a majority of the Federal Court of Appeal regarding the jurisdiction of the Patented Medicine Prices Review Board


Pfizer v. Novopharm, interlocutory motion in PMNOC Regulations case
  • Gowling WLG
  • Canada
  • May 21 2010

Novopharm served a NOA on Pfizer which it had designated confidential


Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case
  • Gowling WLG
  • Canada
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record


Apotex v. Pfizer, motion to strike part of a defence pertaining to res judicata, sildenafil citrate, June 11, 2010
  • Gowling WLG
  • Canada
  • July 16 2010

Apotex applied to impeach Pfizer's patent for Viagra and Pfizer defended alleging, in part, res judicata